Press Releases
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
HKG Epitherapeutics Ltd. Secures CLIA Registration Certificate, A Significant Step Forward in Clinical Laboratory Services
HKG Epitherapeutics Ltd receives CLIA certification, a testament to its dedication to excellence in clinical laboratory testing. Discover the impact of this achievement on the company’s growth and contribution to healthcare innovation.
Pioneering High-Throughput Assay for Swift Detect of Liver Cancer Unveiled by HKG Epitherapeutics Ltd and Collaborat
Discover the groundbreaking high-throughput test developed by HKG Epitherapeutics and partners for the early detection of Hepatocellular Carcinoma. Utilizing distinctive DNA methylation signatures, this revolutionary assay holds the promise of transforming liver cancer detection and saving lives.
HKG EPITHERAPEUTICS LTD Laboratory RECEIVES ACCREDITATION FROM COLLEGE OF AMERICAN PATHOLOGISTS
Hong Kong, January 12, 2022 The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to HKG epiTherapeutics Ltd Laboratory, Hong Kong, based on results of
HIPAA Press Release
HKG Epitherapeutics is pleased to announce that it has achieved compliance with the federally mandated standards of the Health Insurance Portability and Accountability Act (HIPAA) through the use of Compliancy
Beyond the Pap Smear
McGill researchers identify new markers for early detection of cervical cancer. While the mortality rate for cervical cancer has declined dramatically since the 1970s, more than 400 Canadian women succumbed
HKG EpiTherapeutics launches next generation test to discover your biological age
HKG Epitherapeutics is on a mission to improve healthcare and well-being for people worldwide Hong Kong (Sept. 30, 2019) – HKG epiTherapeutics, a Hong Kong-based startup, has announced today the
